Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BioLineRx Ltd. Logo
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
Israel
BLRX
BIOMARIN PHARMACEUTICAL INC Logo
A global biotechnology company developing therapies for rare, life-threatening genetic diseases.
United States of America
BMRN
BioMaxima S.A. Logo
Manufacturer and distributor of in-vitro diagnostics for clinical microbiology.
Poland
BMX
Biomea Fusion, Inc. Logo
A clinical-stage biopharma developing oral drugs for diabetes and obesity.
United States of America
BMEA
BIOMERICA INC Logo
Develops in-vitro diagnostic and therapeutic products for chronic diseases.
United States of America
BMRA
bioMérieux Logo
A global leader in in vitro diagnostics for clinical and industrial applications.
France
BIM
BiomX Inc. Logo
Clinical-stage company developing phage therapies to target harmful bacteria.
United States of America
PHGE
BIONEERCORPORATION Logo
Develops and manufactures molecular biology products for research and diagnostics.
South Korea
064550
BioNTech SE Logo
Biotechnology company developing immunotherapies for cancer and infectious diseases.
United States of America
BNTX
BioPorto Logo
An in vitro diagnostics company specializing in biomarkers for early kidney injury detection.
Denmark
BIOPOR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.